Darshan Singh

Darshan Singh

Author is a pharmaceutical quality and regulatory professional with more than 23 years in drug manufacturing. He holds an M.Sc. in Organic Chemistry and a Diploma in Pharmacy. He has served as Quality Control Head, Quality Assurance Head and Plant Head, overseeing all manufacturing operations. He is co-founder and regulatory consultant at Laafon Galaxy Pharmaceuticals. He writes on SOPs, manufacturing processes, Schedule M compliance and drug pharmacology, and checks each claim against pharmacopoeial and regulatory sources.

Sildenafil Citrate Tablets | L-Force 100mg

Sildenafil Citrate Tablets

Understanding Sildenafil Citrate Tablets 100mg  Introduction: Sildenafil Citrate is a medicine used to treat erectile dysfunction in men. It is also used in pulmonary arterial hypertension (PAH) in both men and women. Sildenafil works by relaxing the muscles of blood…

Pharma Unit for Rent in India – 3 Licensed Units

Pharma Unit for Rent in India

The content provides details on three licensed pharma units available for rent in North India, specifically in Roorkee, Rewari, and Una, with monthly rents ranging from INR 4 lakh to 6.5 lakh. It also explains the licensing routes for manufacturing, emphasizing the importance of verifying documentation before committing to a lease.

NPPA revised the ceiling price of 11 formulations!

The government set up a department called the National Pharmaceutical Pricing Authority (NPPA) to control the prices of medicines in India. This department is tasked with making sure medicine is affordable but also available to everyone. Therefore, NPPA revised the…

156 FDCs ban drugs list 2024

156 FDCs ban drugs list 2024

In a surprise order vide gazzete notification, the Health and Family Welfare Ministry, Government of India issued a 156 FDCs ban drugs list 2024. , The matter was examined by an Expert Committee appointed by the Central Government and the…

Latest DPCO list 2024 after WPI impact

latest dpco list 2024

In the month of March 2024, NPPA the supreme body responsible for fixing the ceiling price of medicines in India announced an increase of 0.00551% increase in the existing prices of medicines that are covered under DPCO Order 2013. In…